Un-medicated individuals ( n = 42 , mean age 560.8 yrs , body mass index 340.6 kg/m ( 2 ) ) were randomised to 12-weeks pioglitazone ( PIO , 15 mg for 6 weeks , then 30 mg daily ) or placebo using a double-blind , parallel group design .